Verastem (VSTM)
(Delayed Data from NSDQ)
$2.96 USD
-0.01 (-0.34%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $2.97 +0.01 (0.34%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Brokerage Reports
0 items in cart
Verastem, Inc. [VSTM]
Reports for Purchase
Showing records 261 - 266 ( 266 total )
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Compounds and Stem Cell Science Take Center Stage at AACR
Provider: RODMAN & RENSHAW, CO.
Analyst: KING M
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Compounds and Stem Cell Science Take Center Stage at AACR
Provider: RODMAN & RENSHAW, CO.
Analyst: KING M
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
We are initiating coverage with a Market Outperform rating and a price target of $19.
Provider: RODMAN & RENSHAW, CO.
Analyst: KING M
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
We are initiating coverage with a Market Outperform rating and a price target of $19.
Provider: RODMAN & RENSHAW, CO.
Analyst: KING M